Bio Pharma Dive
DECEMBER 30, 2020
The first public vaccinations with AstraZeneca and Oxford’s shot will begin early in the New Year. But it’s still unclear how effective the vaccine is, or the best way to use it.
World of DTC Marketing
DECEMBER 29, 2020
OBSERVATION: Biologics can take a long time to develop but COVID vaccines have been in development for almost 50 years and novel approaches were used to develop these vaccines. Vaccines typically take 10 to 15 years to develop, test and release to the public. The coronavirus vaccines, however, took less than a year. Why? First, a novel approach was used that didn’t require traditional vaccine production in cell cultures or eggs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
DECEMBER 30, 2020
Axsome Therapeutics reported positive data from the long-term, open-label Phase III MOVEMENT trial of AXS-07 for the treatment of acute migraine.
Scienmag
JANUARY 1, 2021
Data from Phase 3 clinical trial confirm vaccine is effective Credit: NIH WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe […].
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
DECEMBER 29, 2020
This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.
World of DTC Marketing
DECEMBER 28, 2020
As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. Much has changed but a lot is also the same. Business magazines are writing about the “digital future” of healthcare but are consumers ready? Some are, but most aren’t. First, let’s dispel a recent topic: telehealth.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Marketing Network
DECEMBER 29, 2020
2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative platforms to keep physicians, providers and patients informed, engaged and empowered. As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connec
Druggist
DECEMBER 28, 2020
Fexofenadine recently received a green light and soon will be available over the counter without a prescription. Until now, fexofenadine was a prescription-only medication. The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets.
Pharmacy Checkers
DECEMBER 30, 2020
Here’s a kind of funny story to end the year with. I make a big deal on these pages about the decriminalized reality of personal drug importation. Federal law prohibits under most circumstances importing prescription drugs for your own use, but people are never busted for it. I’ve been around this a long time and I mean never. But that’s for personal use only.
BioSpace
DECEMBER 27, 2020
The vaccine will be able to be administered without needles and in one dose. It also won’t require refrigeration.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
NY Times
DECEMBER 28, 2020
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
Scienmag
DECEMBER 30, 2020
The SUTD study will be crucial for assessing future climatic changes and making more informed water management decisions. Credit: SUTD 813 years of annual river discharge at 62 stations, 41 rivers in 16 countries, from 1200 to 2012. That is what researchers at the Singapore University of Technology and Design (SUTD) produced after two years […].
Drug Patent Watch
DECEMBER 30, 2020
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug. INVELTYS drug…. The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
DECEMBER 30, 2020
From synthetic polymer-based anti-infectives to antiviral conjugates and DNA vaccines, the past year has given new and emerging drug classes an opportunity to shine.
NY Times
DECEMBER 30, 2020
We should expect some people to experience side effects. The shot is still safer than the disease.
Scienmag
DECEMBER 29, 2020
Observational clinical research of COVID-19 patients can help clinicians better understand how the previously unknown SARS-CoV-2 virus acts, and findings from this research can better inform treatment and vaccine design. Credit: UAB BIRMINGHAM, Ala. – COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or […].
BioPharma Reporter
DECEMBER 30, 2020
The UK has authorized emergency supply of AstraZeneca's COVID-19 vaccine: with the first vaccinations set to begin early in the new year.
BioSpace
DECEMBER 30, 2020
If 2020 taught us anything, it was that unexpected things happen. That said, there are some stories we’ll be watching for. Here’s a look.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
JAMA Internal Medicine
DECEMBER 27, 2020
This comparative effectiveness study assesses whether the health outcomes of White US citizens living in the 1% and 5% richest counties are better than the health outcomes of average residents in other developed countries.
Scienmag
JANUARY 1, 2021
Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19 infections and severe illness BOSTON — A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.
XTalks
DECEMBER 28, 2020
In today’s modern world, a plethora of new technologies have been instrumental in creating new foods, especially plant-based foods. But even with today’s available food tech, some of America’s most popular foods were born out of necessity for, and by, the US military — the necessity being to develop compact and nutritional ways to feed soldiers. The food processing techniques pioneered by the military didn’t just stay within the military.
BioSpace
DECEMBER 28, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
JAMA Internal Medicine
DECEMBER 27, 2020
This cohort study uses data from the electronic health record of patients admitted to Cleveland Clinic Hospitals to assess the outcomes of adults with noncardiac inpatient admissions who were treated for hypertension.
Scienmag
JANUARY 1, 2021
Study links cost-related relocations to reduced access to prescribed drugs and medical services Credit: Photo by Cedars-Sinai LOS ANGELES (Dec. 30, 2020) — People who move due to unaffordable housing are at increased risk of failing to receive the medical care they need, according to a new study from Cedars-Sinai and the University of California, […].
NY Times
DECEMBER 28, 2020
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
BioSpace
DECEMBER 28, 2020
The U.S. Department of Defense awarded Moderna a contract worth $1,966,598,000 for an additional 100 million doses of its COVID-19 vaccine.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Druggist
DECEMBER 31, 2020
Vibegron (brand name: Gemtesa) is the latest drug used to treat overactive bladder that has been approved by the FDA in the USA. Gemtesa will be available in the US as prescription-only medication from April 2021. In this post, I will summarise: . Licensed use and legal status of vibegron (US). It’s a mechanism of action . The effectiveness of vibegron: summary of clinical trial . vibegron vs mirabegron: what is the difference?
Scienmag
JANUARY 1, 2021
Credit: The research team. In some cases, immune cells in the lungs can contribute to worsening a virus attack. In a new study, researchers at Karolinska Institutet in Sweden describe how different kinds of immune cells, called macrophages, develop in the lungs and which of them may be behind severe lung diseases. The study, which […].
NY Times
DECEMBER 28, 2020
Doctors often prescribe them for sore throats and the common cold, even though evidence of benefit is sorely lacking.
BioSpace
DECEMBER 29, 2020
A great deal remains unknown about the SARS-CoV-2 virus, its mutations, transmissibility and long-term effects. Here’s what we do know.
Expert insights. Personalized for you.
340 
Let's personalize your content